关于欧洲肿瘤内科学会（ESMO）现行转移性结直肠癌患者管理共识指南在低收入和中等收入国家资源受限环境中的实用笔记。
Practical notes on the current ESMO consensus guidelines for the management of patients with metastatic colorectal cancer in resource-constrained environments of low- to middle-income countries.
作者信息
Maurel Jean-Marc, Tamayo Maria Belen, Pitargue Rosario, Ong-Cornel Annielyn Beryl, Mehta Piyush, Diouf Doudou, Deshmukh Chetan, Basade Maheboob, Balde Salif, Adanza-Cutillar Eunice, Dawood Shaheenah
出版信息
Oncology. 2023 Mar 23;101(1):5-8. doi: 10.1159/000530275.
Abstract
Letter (no abstract).
摘要
信函（无摘要）。
相似文献
1
Practical notes on the current ESMO consensus guidelines for the management of patients with metastatic colorectal cancer in resource-constrained environments of low- to middle-income countries.关于欧洲肿瘤内科学会（ESMO）现行转移性结直肠癌患者管理共识指南在低收入和中等收入国家资源受限环境中的实用笔记。
Oncology. 2023 Mar 23;101(1):5-8. doi: 10.1159/000530275.
2
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.泛亚地区转移性结直肠癌管理的 ESMO 共识指南：日本临床肿瘤学会-欧洲肿瘤内科学会、韩国癌症学会、中国临床肿瘤学会、韩国肿瘤学会和日本肿瘤外科学会共同支持的一项 JSMO-ESMO 倡议。
Ann Oncol. 2018 Jan 1;29(1):44-70. doi: 10.1093/annonc/mdx738.
3
Treatment of Metastatic Colorectal Cancers in Resource-Constrained Low- and Middle-Income Countries (LMICS) Scenario-Outcomes, Practice Patterns, and Commentary on Treatment Costs.资源受限的低收入和中等收入国家（LMICS）中转移性结直肠癌的治疗——结果、实践模式及治疗成本评论
South Asian J Cancer. 2022 Sep 2;11(4):293-298. doi: 10.1055/s-0041-1736203. eCollection 2022 Oct.
4
Management of fracture-related infection in low resource settings: how applicable are the current consensus guidelines?资源匮乏地区骨折相关感染的管理：当前的共识指南适用性如何？
EFORT Open Rev. 2022 May 31;7(6):422-432. doi: 10.1530/EOR-22-0031.
5
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.泛亚地区调整的 ESMO 临床实践指南：局部晚期不可切除的非小细胞肺癌患者管理：一项由 KSMO-ESMO 发起、CSCO、ISMPO、JSMO、MOS、SSO 和 TOS 支持的倡议。
Ann Oncol. 2020 Feb;31(2):191-201. doi: 10.1016/j.annonc.2019.10.026. Epub 2019 Dec 20.
6
Recommendation on testing for dihydropyrimidine dehydrogenase deficiency in the ESMO consensus guidelines for the management of patients with metastatic colorectal cancer.欧洲肿瘤内科学会（ESMO）转移性结直肠癌患者管理共识指南中关于二氢嘧啶脱氢酶缺乏症检测的建议。
Ann Oncol. 2017 Jan 1;28(1):184. doi: 10.1093/annonc/mdw533.
7
Diagnosis and Management of Diffuse Large B-Cell Lymphoma: Society of Medical Oncology, Pakistan Society of Hematology, and Pakistan Society of Clinical Oncology Joint Clinical Practice Guideline.弥漫性大 B 细胞淋巴瘤的诊断与治疗：医学肿瘤学会、巴基斯坦血液病学会和巴基斯坦临床肿瘤学会联合临床实践指南。
JCO Glob Oncol. 2021 Sep;7:1647-1658. doi: 10.1200/GO.21.00320.
8
EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.EURECCA 结直肠：多学科管理：欧洲共识会议结肠和直肠。
Eur J Cancer. 2014 Jan;50(1):1.e1-1.e34. doi: 10.1016/j.ejca.2013.06.048. Epub 2013 Oct 31.
9
ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee.ESMO 共识会议关于局部区域黑色素瘤管理的建议：在 ESMO 指南委员会的主持下。
Ann Oncol. 2020 Nov;31(11):1449-1461. doi: 10.1016/j.annonc.2020.07.005. Epub 2020 Aug 4.
10
Supportive and palliative care for metastatic breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement.转移性乳腺癌的支持性和姑息治疗：中低收入国家的资源配置。2013 年乳腺健康全球倡议共识声明。
Breast. 2013 Oct;22(5):616-27. doi: 10.1016/j.breast.2013.07.052. Epub 2013 Aug 21.
引用本文的文献
1
Collagen disorder architecture features are associated with clinical, molecular, genetic factors and survival outcomes in colon cancer.胶原蛋白紊乱结构特征与结肠癌的临床、分子、遗传因素及生存结果相关。
NPJ Precis Oncol. 2025 Aug 28;9(1):304. doi: 10.1038/s41698-025-01098-y.
2
Identification of cuproptosis and ferroptosis-related subtypes and development of a prognostic signature in colon cancer.结肠癌中铜死亡和铁死亡相关亚型的鉴定及预后特征的建立
PLoS One. 2025 Jan 30;20(1):e0307013. doi: 10.1371/journal.pone.0307013. eCollection 2025.
3
Complete remission in a pretreated, microsatellite-stable, -mutated colon cancer patient after treatment with sintilimab and bevacizumab and platinum-based chemotherapy: a case report and literature review.信迪利单抗联合贝伐单抗及铂类化疗治疗后，一名预处理过的微卫星稳定、突变型结肠癌患者达到完全缓解：病例报告及文献综述
Front Immunol. 2024 Mar 28;15:1354613. doi: 10.3389/fimmu.2024.1354613. eCollection 2024.
本文引用的文献
1
Access to and Affordability of World Health Organization Essential Medicines for Cancer in Sub-Saharan Africa: Examples from Kenya, Rwanda, and Uganda.撒哈拉以南非洲获得世界卫生组织癌症基本药物的机会和可负担性：肯尼亚、卢旺达和乌干达的实例。
Oncologist. 2022 Nov 3;27(11):958-970. doi: 10.1093/oncolo/oyac143.
2
Testing for Dihydropyrimidine Dehydrogenase Deficiency to Individualize 5-Fluorouracil Therapy.检测二氢嘧啶脱氢酶缺乏症以个体化5-氟尿嘧啶治疗。
Cancers (Basel). 2022 Jun 30;14(13):3207. doi: 10.3390/cancers14133207.
3
Cost-effectiveness of DPYD Genotyping Prior to Fluoropyrimidine-based Adjuvant Chemotherapy for Colon Cancer.氟嘧啶类辅助化疗前进行 DPYD 基因分型的成本效益分析：用于结肠癌。
Clin Colorectal Cancer. 2022 Sep;21(3):e189-e195. doi: 10.1016/j.clcc.2022.05.001. Epub 2022 May 11.
4
Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家结直肠癌及其危险因素负担，1990-2019 年：2019 年全球疾病负担研究的系统分析。
Lancet Gastroenterol Hepatol. 2022 Jul;7(7):627-647. doi: 10.1016/S2468-1253(22)00044-9. Epub 2022 Apr 7.
5
A systematic review on the cost effectiveness of pharmacogenomics in developing countries: implementation challenges.系统评价在发展中国家实施药物基因组学的成本效益：实施挑战。
Pharmacogenomics J. 2022 May;22(3):147-159. doi: 10.1038/s41397-022-00272-w. Epub 2022 Mar 22.
6
Age-standardised incidence rate and epidemiology of colorectal cancer in Africa: a systematic review and meta-analysis.非洲结直肠癌的年龄标准化发病率和流行病学：系统评价和荟萃分析。
BMJ Open. 2022 Jan 17;12(1):e052376. doi: 10.1136/bmjopen-2021-052376.
7
Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era.精准医学时代下 RAS 野生型/突变型转移性结直肠癌的循证二线治疗。
Int J Mol Sci. 2021 Jul 19;22(14):7717. doi: 10.3390/ijms22147717.
8
Colorectal Cancers in Low- and Middle-Income Countries-Demographic Pattern and Clinical Profile of 970 Patients Treated at a Tertiary Care Cancer Center in India.中低收入国家的结直肠癌-在印度一家三级癌症治疗中心治疗的 970 名患者的人口统计学模式和临床特征。
JCO Glob Oncol. 2021 Jul;7:1110-1115. doi: 10.1200/GO.21.00111.
9
The Road so Far in Colorectal Cancer Pharmacogenomics: Are We Closer to Individualised Treatment?结直肠癌药物基因组学的现状：我们离个性化治疗更近了吗？
J Pers Med. 2020 Nov 19;10(4):237. doi: 10.3390/jpm10040237.
10
Enhancing global access to cancer medicines.加强全球获取癌症药物的机会。
CA Cancer J Clin. 2020 Mar;70(2):105-124. doi: 10.3322/caac.21597. Epub 2020 Feb 18.
Zotero 插件